Target Validation Information
Target ID T51565
Target Name Casein kinase II, alpha chain
Target Type
Discontinued
Drug Potency against Target 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole Drug Info IC50 = 13000 nM [530101]
APIGENIN Drug Info IC50 = 800 nM [530101]
4,5,6,7-tetrabromo-1H-benzo[d][1,2,3]triazole Drug Info IC50 = 900 nM [530101]
5,6,8-trichloroquinoline-4-one-3-carboxylic acid Drug Info IC50 = 300 nM [528489]
EMODIN Drug Info IC50 = 2000 nM [530101]
ELLAGIC ACID Drug Info IC50 = 40 nM [530101]
7,8-dichloroquinoline-4-one-3-carboxylic acid Drug Info IC50 = 800 nM [528489]
4,5,6,7-tetrabromo-1H-benzimidazole Drug Info IC50 = 1300 nM [529933]
BALANOL Drug Info IC50 = 30 nM [534297]
CGP-029482 Drug Info IC50 = 390 nM [530101]
AdoC(Dpr)2AlaArg6 Drug Info IC50 = 17000 nM [525511]
References
Ref 530101Bioorg Med Chem Lett. 2009 Jun 1;19(11):2920-3. Epub 2009 Apr 22.Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
Ref 530101Bioorg Med Chem Lett. 2009 Jun 1;19(11):2920-3. Epub 2009 Apr 22.Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
Ref 530101Bioorg Med Chem Lett. 2009 Jun 1;19(11):2920-3. Epub 2009 Apr 22.Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
Ref 528489J Med Chem. 2006 Nov 2;49(22):6443-50.Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2.
Ref 530101Bioorg Med Chem Lett. 2009 Jun 1;19(11):2920-3. Epub 2009 Apr 22.Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
Ref 530101Bioorg Med Chem Lett. 2009 Jun 1;19(11):2920-3. Epub 2009 Apr 22.Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
Ref 528489J Med Chem. 2006 Nov 2;49(22):6443-50.Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2.
Ref 529933Bioorg Med Chem. 2009 Feb 15;17(4):1573-8. Epub 2009 Jan 7.Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2.
Ref 534297J Med Chem. 1996 Dec 20;39(26):5215-27.Synthesis and protein kinase C inhibitory activities of acyclic balanol analogs that are highly selective for protein kinase C over protein kinase A.
Ref 530101Bioorg Med Chem Lett. 2009 Jun 1;19(11):2920-3. Epub 2009 Apr 22.Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
Ref 525511Bioorg Med Chem Lett. 1999 May 17;9(10):1447-52.Adenosine-5'-carboxylic acid peptidyl derivatives as inhibitors of protein kinases.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.